BDRX
Biodexa Pharmaceuticals
BDRX
BDRX
4 hedge funds and large institutions have $31.2K invested in Biodexa Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GI
1
GAMMA Investing
Foster City,
California
|
$18K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$3.95K |
Top Sellers
| 1 |
BFM
1
Boothbay Fund Management
New York
|
$0 |
| 2 |
2
Renaissance Technologies
New York
|
$0 |
| 3 |
3
Morgan Stanley
New York
|
$26 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GI
1
GAMMA Investing
Foster City,
California
| $18K | +$16.3K | +40 | +1,000% |
|
2
Bank of America
Charlotte,
North Carolina
| $8.48K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $3.95K | +$3.16K | +8 | +400% |
|
4
RhumbLine Advisers
Boston,
Massachusetts
| $806 | – | – | – |
|
|
5
Morgan Stanley
New York
| $26 | -$86 | – | – |
|
|
BFM
6
Boothbay Fund Management
New York
| – | -$120K | -178 | Closed |
|
|
7
Renaissance Technologies
New York
| – | -$31K | -47 | Closed |
|